Thor Medical ASA (FRA:8NN)

Thor Medical ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	21.89	13.29	3.14	-
Other Operating Expenses	30.06	28.26	3.69	-
Operating Expenses	64.13	43.93	7.16	-
Operating Income	-64.03	-43.93	-7.16	-
Interest Expense	-0.2	-0.1	-	-
Interest & Investment Income	1.75	1.45	2.02	-
Currency Exchange Gain (Loss)	1.14	-0.06	-0.25	-
Other Non Operating Income (Expenses)	-0.09	0.01	-0.17	-
Pretax Income	-61.44	-42.64	-5.56	-
Income Tax Expense	-2.53	-0.43	-	-
Earnings From Continuing Operations	-58.91	-42.21	-5.56	-
Earnings From Discontinued Operations	-	-	-21	-311.24
Net Income	-58.91	-42.21	-26.56	-311.24
Net Income to Common	-58.91	-42.21	-26.56	-311.24
Shares Outstanding (Basic)	274	236	175	115
Shares Outstanding (Diluted)	274	236	175	115
Shares Change (YoY)	17.08%	34.90%	51.82%	-
EPS (Basic)	-0.22	-0.18	-0.15	-2.70
EPS (Diluted)	-0.22	-0.18	-0.15	-2.70
Free Cash Flow	-74.22	-24.12	-64.09	-414.71
Free Cash Flow Per Share	-0.27	-0.10	-0.37	-3.60
EBITDA	-51.85	-41.55	-6.83	-
D&A For EBITDA	12.18	2.38	0.33	-
EBIT	-64.03	-43.93	-7.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.